Kevin Tay

1.1k total citations
22 papers, 321 citations indexed

About

Kevin Tay is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Kevin Tay has authored 22 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 9 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Kevin Tay's work include Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Viral-associated cancers and disorders (4 papers). Kevin Tay is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Viral-associated cancers and disorders (4 papers). Kevin Tay collaborates with scholars based in Singapore, United States and South Korea. Kevin Tay's co-authors include Kieron Dunleavy, Wyndham H. Wilson, Soon Thye Lim, Miriam Tao, Richard Quek, Soo‐Yong Tan, Tiffany Tang, Won Seog Kim, Leonard Tan and Alexandre Chan and has published in prestigious journals such as Chemical Reviews, Journal of Clinical Oncology and Blood.

In The Last Decade

Kevin Tay

21 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin Tay Singapore 11 187 164 101 71 51 22 321
Marjolein van der Poel Netherlands 10 130 0.7× 184 1.1× 52 0.5× 44 0.6× 23 0.5× 32 299
Rafael Dezen Gaiolla Brazil 8 218 1.2× 187 1.1× 124 1.2× 64 0.9× 40 0.8× 20 362
Lynny Yung United Kingdom 5 227 1.2× 184 1.1× 60 0.6× 55 0.8× 19 0.4× 7 315
Gianpaolo Marcacci Italy 8 192 1.0× 115 0.7× 60 0.6× 129 1.8× 22 0.4× 17 313
Sheila Nair India 10 199 1.1× 127 0.8× 66 0.7× 49 0.7× 11 0.2× 32 301
Ruemu Birhiray United States 8 80 0.4× 80 0.5× 51 0.5× 81 1.1× 50 1.0× 32 241
Avyakta Kallam United States 9 102 0.5× 104 0.6× 32 0.3× 66 0.9× 39 0.8× 52 249
Xiaojie Fang China 12 112 0.6× 115 0.7× 38 0.4× 26 0.4× 63 1.2× 52 329
Silvia Trappolini Italy 7 79 0.4× 48 0.3× 96 1.0× 42 0.6× 39 0.8× 13 290
Javed Gill United States 7 144 0.8× 116 0.7× 46 0.5× 94 1.3× 76 1.5× 12 290

Countries citing papers authored by Kevin Tay

Since Specialization
Citations

This map shows the geographic impact of Kevin Tay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Tay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Tay more than expected).

Fields of papers citing papers by Kevin Tay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Tay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Tay. The network helps show where Kevin Tay may publish in the future.

Co-authorship network of co-authors of Kevin Tay

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Tay. A scholar is included among the top collaborators of Kevin Tay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Tay. Kevin Tay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xinyi, Wei Heng Chng, Kevin Tay, et al.. (2025). Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs. Chemical Reviews. 125(21). 10248–10341. 1 indexed citations
2.
Narayanan, A. Sampath, et al.. (2024). Quantitative Analysis of Tooth-Whitening Efficiency Using Natural Bleaching Agents: An In Vitro Spectrophotometric Evaluation. Journal of international oral health. 16(5). 374–379.
3.
Yoon, Sang Eun, Seung Ju Kim, Dok Hyun Yoon, et al.. (2020). 257O Intercontinental cooperative non-Hodgkin T-cell lymphoma prospective registry study in Asia: ICT study. Annals of Oncology. 31. S1343–S1344. 1 indexed citations
4.
Tang, Tiffany, Kevin Tay, Miriam Tao, et al.. (2016). A Phase II Study of Bortezomib-GIFOX (Gemcitabine, Ifosfamide, Oxaliplatin) in Patients with Newly Diagnosed Natural-Killer/T-Cell Lymphoma. Blood. 128(22). 5353–5353. 10 indexed citations
5.
Tan, Daryl, Colin Phipps, William Ying Khee Hwang, et al.. (2015). Panobinostat in combination with bortezomib in patients with relapsed or refractory peripheral T-cell lymphoma: an open-label, multicentre phase 2 trial. The Lancet Haematology. 2(8). e326–e333. 44 indexed citations
6.
Lee, Joycelyn Jie Xin, Soo‐Yong Tan, Hwei Yee Lee, et al.. (2014). One Patient, Two Uncommon B-Cell Neoplasms: Solitary Plasmacytoma following Complete Remission from Intravascular Large B-Cell Lymphoma Involving Central Nervous System. Case Reports in Medicine. 2014. 1–6. 4 indexed citations
7.
Hwang, William Ying Khee, Colin Phipps Diong, Kevin Tay, et al.. (2014). A Phase 2 Study of Panobinostat (PAN) in Combination with Bortezomib (BTZ) in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) or NK/T-Cell Lymphoma (NKL). Blood. 124(21). 503–503. 4 indexed citations
8.
Lim, Soon Thye, et al.. (2013). Cytomegalovirus infection and end-organ disease in Asian patients with lymphoma receiving chemotherapy. Leukemia & lymphoma. 55(1). 182–187. 17 indexed citations
9.
Kim, Seok Jin, Hyun Ae Jung, Shih‐Sung Chuang, et al.. (2013). Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma study group. Journal of Hematology & Oncology. 6(1). 86–86. 55 indexed citations
10.
Chua, Clarinda, Mohamad Farid, Kesavan Sittampalam, et al.. (2013). Brain metastasis in sarcoma: Does metastasectomy or aggressive multi‐disciplinary treatment improve survival outcomes. Asia-Pacific Journal of Clinical Oncology. 12(1). e16–22. 16 indexed citations
11.
Tan, Leonard, et al.. (2012). Does the proliferation fraction help identify mature B cell lymphomas with double‐ and triple‐hit translocations?. Histopathology. 61(6). 1214–1218. 27 indexed citations
12.
Chan, Alexandre, Vivianne Shih, Lita Chew, et al.. (2012). Clinical pharmacy services and research for lymphoma patients at a cancer center. Journal of Oncology Pharmacy Practice. 19(1). 24–30. 14 indexed citations
13.
Chan, Alexandre, et al.. (2011). Management of tumor lysis syndrome with a single fixed dose of rasburicase in Asian lymphoma patients: A case series and literature review. Asia-Pacific Journal of Clinical Oncology. 7(4). 351–356. 9 indexed citations
14.
Chan, Alexandre, et al.. (2010). Comparison of daily filgrastim and pegfilgrastim to prevent febrile neutropenia in Asian lymphoma patients. Asia-Pacific Journal of Clinical Oncology. 7(1). 75–81. 12 indexed citations
15.
Tay, Kevin, Kieron Dunleavy, & Wyndham H. Wilson. (2010). Novel agents for B-cell non-Hodgkin lymphoma: Science and the promise. Blood Reviews. 24(2). 69–82. 9 indexed citations
16.
Dunleavy, Kieron, Kevin Tay, & Wyndham H. Wilson. (2010). Rituximab-Associated Neutropenia. Seminars in Hematology. 47(2). 180–186. 57 indexed citations
17.
Tang, Tiffany, Kevin Tay, Richard Quek, et al.. (2010). Peripheral T-Cell Lymphoma: Review and Updates of Current Management Strategies. Advances in Hematology. 2010. 1–8. 12 indexed citations
18.
Tay, Kevin, Geoffrey I. Shapiro, Lucian R. Chirieac, et al.. (2009). Phase I/II study of a hybrid schedule of flavopiridol in relapsed/refractory mantle cell lymphoma (MCL) and diffuse large B-cell lymphoma (DLBCL). Journal of Clinical Oncology. 27(15_suppl). 8563–8563. 6 indexed citations
19.
Dunleavy, Kieron, Stefania Pittaluga, Kevin Tay, et al.. (2009). Comparative Clinical and Biological Features of Primary Mediastinal B-Cell Lymphoma (PMBL) and Mediastinal Grey Zone Lymphoma (MGZL).. Blood. 114(22). 106–106. 10 indexed citations
20.
Dunleavy, Kieron, Stefania Pittaluga, Nicole Grant, et al.. (2008). Gray Zone Lymphomas: Clinical and Histological Characteristics and Treatment with Dose-Adjusted-EPOCH-R. Blood. 112(11). 3590–3590. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marjolein van der Poel Breakdown of academic impact, for papers by Rafael Dezen Gaiolla Breakdown of academic impact, for papers by Lynny Yung Breakdown of academic impact, for papers by Gianpaolo Marcacci Breakdown of academic impact, for papers by Sheila Nair Breakdown of academic impact, for papers by Ruemu Birhiray Breakdown of academic impact, for papers by Avyakta Kallam Breakdown of academic impact, for papers by Xiaojie Fang Breakdown of academic impact, for papers by Silvia Trappolini Breakdown of academic impact, for papers by Javed Gill
Rankless by CCL
2026